Authors: |
Yeh TC; Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.; Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, Taipei, Taiwan., Lin YY; Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.; Department of Emergency Medicine, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan.; Department of Life Sciences, National Central University, Taoyuan, Taiwan., Tzeng NS; Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan., Kao YC; Department of Psychiatry, Tri-Service General Hospital Beitou Branch, National Defense Medical Center, Taipei, Taiwan., Chung YA; Department of Nuclear Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Chang CC; Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan., Fang HW; Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, Taipei, Taiwan.; Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli County, Taiwan.; High-Value Biomaterials Research and Commercialization Center, National Taipei University of Technology, Taipei, Taiwan., Chang HA; Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. |
Language: |
English |
References: |
Solmi M, Seitidis G, Mavridis D et al. Incidence, prevalence, and global burden of schizophrenia – Data, with critical appraisal, from the global burden of disease (GBD) 2019. Mol. Psychiatry 2023; 28: 5319–5327. Arias D, Saxena S, Verguet S. Quantifying the global burden of mental disorders and their economic value. EClinicalMedicine 2022; 54: 101675. Veerman SRT, Schulte PFJ, de Haan L. Treatment for negative symptoms in schizophrenia: A comprehensive review. Drugs 2017; 77: 1423–1459. Potkin SG, Alva G, Fleming K et al. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am. J. Psychiatry 2002; 159: 227–237. Townsend L, Pillinger T, Selvaggi P, Veronese M, Turkheimer F, Howes O. Brain glucose metabolism in schizophrenia: A systematic review and meta‐analysis of (18)FDG‐PET studies in schizophrenia. Psychol. Med. 2023; 53: 4880–4897. Xu P, Klaasen NG, Opmeer EM et al. Intrinsic mesocorticolimbic connectivity is negatively associated with social amotivation in people with schizophrenia. Schizophr. Res. 2019; 208: 353–359. Giordano GM, Stanziano M, Papa M et al. Functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia: A resting state functional MRI study. Eur. Neuropsychopharmacol. 2018; 28: 589–602. Tseng PT, Zeng BS, Hung CM et al. Assessment of noninvasive brain stimulation interventions for negative symptoms of schizophrenia: A systematic review and network meta‐analysis. JAMA Psychiatry 2022; 79: 770–779. Zeev‐Wolf M, Levy J, Jahshan C et al. MEG resting‐state oscillations and their relationship to clinical symptoms in schizophrenia. Neuroimage Clin. 2018; 20: 753–761. Ambrosen KS, Fredriksson F, Anhoj S et al. Clustering of antipsychotic‐naive patients with schizophrenia based on functional connectivity from resting‐state electroencephalography. Eur. Arch. Psychiatry Clin. Neurosci. 2023; 273: 1785–1796. Kraguljac NV, White DM, Hadley JA et al. Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone. Neuroimage Clin. 2016; 10: 146–158. Yeh TC, Huang CC, Chung YA et al. High‐frequency transcranial random noise stimulation modulates gamma‐band EEG source‐based large‐scale functional network connectivity in patients with schizophrenia: A randomized, double‐blind, sham‐controlled clinical trial. J. Pers. Med. 2022; 12: 1617. Wang X, Zhang Y, Long Z et al. Frequency‐specific alteration of functional connectivity density in antipsychotic‐naive adolescents with early‐onset schizophrenia. J. Psychiatr. Res. 2017; 95: 68–75. Villamar MF, Volz MS, Bikson M, Datta A, Dasilva AF, Fregni F. Technique and considerations in the use of 4×1 ring high‐definition transcranial direct current stimulation (HD‐tDCS). J. Vis. Exp. 2013; 77: e50309. Chang CC, Kao YC, Chao CY, Tzeng NS, Chang HA. Examining bi‐anodal transcranial direct current stimulation (tDCS) over bilateral dorsolateral prefrontal cortex coupled with bilateral extracephalic references as a treatment for negative symptoms in non‐acute schizophrenia patients: A randomized, double‐blind, sham‐controlled trial. Prog. Neuropsychopharmacol. Biol. Psychiatry 2020; 96: 109715. Valiengo L, Goerigk S, Gordon PC et al. Efficacy and safety of transcranial direct current stimulation for treating negative symptoms in schizophrenia: A randomized clinical trial. JAMA Psychiatry 2020; 77: 121–129. Yamada Y, Narita Z, Inagawa T et al. Electrode montage for transcranial direct current stimulation governs its effect on symptoms and functionality in schizophrenia. Front. Psychiatry 2023; 14: 14. Xu H, Zhou Y, Wang J et al. Effect of HD‐tDCS on white matter integrity and associated cognitive function in chronic schizophrenia: A double‐blind, sham‐controlled randomized trial. Psychiatry Res. 2023; 324: 115183. Dharani R, Goyal N, Mukherjee A, Umesh S. Adjuvant high‐definition transcranial direct current stimulation for negative symptoms in schizophrenia: A pilot study. J. ECT 2021; 37: 195–201. Brunoni AR, Nitsche MA, Bolognini N et al. Clinical research with transcranial direct current stimulation (tDCS): Challenges and future directions. Brain Stimul. 2012; 5: 175–195. Ma CC, Lin YY, Chung YA et al. The two‐back task leads to activity in the left dorsolateral prefrontal cortex in schizophrenia patients with predominant negative symptoms: A fNIRS study and its implication for tDCS. Exp. Brain Res. 2024; 242: 585–597. Windhoff M, Opitz A, Thielscher A. Electric field calculations in brain stimulation based on finite elements: An optimized processing pipeline for the generation and usage of accurate individual head models. Hum. Brain Mapp. 2013; 34: 923–935. Brunoni AR, Amadera J, Berbel B, Volz MS, Rizzerio BG, Fregni F. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int. J. Neuropsychopharmacol. 2011; 14: 1133–1145. Marder SR, Davis JM, Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the north American trials. J. Clin. Psychiatry 1997; 58: 538–546. Howes OD, McCutcheon R, Agid O et al. Treatment‐resistant schizophrenia: Treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am. J. Psychiatry 2017; 174: 216–229. Iseger TA, Arns M, Downar J, Blumberger DM, Daskalakis ZJ, Vila‐Rodriguez F. Cardiovascular differences between sham and active iTBS related to treatment response in MDD. Brain Stimul. 2020; 13: 167–174. Iseger TA, van Bueren NER, Kenemans JL, Gevirtz R, Arns M. A frontal‐vagal network theory for major depressive disorder: Implications for optimizing neuromodulation techniques. Brain Stimul. 2020; 13: 1–9. Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biol. Psychiatry 2006; 59: 990–996. Furukawa TA, Leucht S. How to obtain NNT from Cohen's d: Comparison of two methods. PLoS One 2011; 6: e19070. Chang CY, Hsu SH, Pion‐Tonachini L, Jung TP. Evaluation of artifact subspace reconstruction for automatic artifact components removal in multi‐channel EEG recordings. I.E.E.E. Trans. Biomed. Eng. 2020; 67: 1114–1121. Pion‐Tonachini L, Kreutz‐Delgado K, Makeig S. ICLabel: An automated electroencephalographic independent component classifier, dataset, and website. Neuroimage 2019; 198: 181–197. Pascual‐Marqui RD, Lehmann D, Koukkou M et al. Assessing interactions in the brain with exact low‐resolution electromagnetic tomography. Philos. Transact. A Math. Phys. Eng. Sci. 2011; 369: 3768–3784. Fuchs M, Kastner J, Wagner M, Hawes S, Ebersole JS. A standardized boundary element method volume conductor model. Clin. Neurophysiol. 2002; 113: 702–712. Mazziotta J, Toga A, Evans A et al. A probabilistic atlas and reference system for the human brain: International consortium for brain mapping (ICBM). Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001; 356: 1293–1322. Lancaster JL, Woldorff MG, Parsons LM et al. Automated Talairach atlas labels for functional brain mapping. Hum. Brain Mapp. 2000; 10: 120–131. Yeo BT, Krienen FM, Sepulcre J et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J. Neurophysiol. 2011; 106: 1125–1165. Whitton AE, Deccy S, Ironside ML, Kumar P, Beltzer M, Pizzagalli DA. Electroencephalography source functional connectivity reveals abnormal high‐frequency communication among large‐scale functional networks in depression. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2018; 3: 50–58. Olbrich S, Mulert C, Karch S et al. EEG‐vigilance and BOLD effect during simultaneous EEG/fMRI measurement. Neuroimage 2009; 45: 319–332. Kuo HI, Bikson M, Datta A et al. Comparing cortical plasticity induced by conventional and high‐definition 4 × 1 ring tDCS: A neurophysiological study. Brain Stimul. 2013; 6: 644–648. Leodori G, Thirugnanasambandam N, Conn H, Popa T, Berardelli A, Hallett M. Intracortical inhibition and surround inhibition in the motor cortex: A TMS‐EEG study. Front. Neurosci. 2019; 13: 612. Nitsche MA, Liebetanz D, Schlitterlau A et al. GABAergic modulation of DC stimulation‐induced motor cortex excitability shifts in humans. Eur. J. Neurosci. 2004; 19: 2720–2726. Lindenmayer JP, Kulsa MKC, Sultana T et al. Transcranial direct‐current stimulation in ultra‐treatment‐resistant schizophrenia. Brain Stimul. 2019; 12: 54–61. Kantrowitz JT, Sehatpour P, Avissar M et al. Significant improvement in treatment resistant auditory verbal hallucinations after 5 days of double‐blind, randomized, sham controlled, fronto‐temporal, transcranial direct current stimulation (tDCS): A replication/extension study. Brain Stimul. 2019; 12: 981–991. Chang CC, Tzeng NS, Chao CY, Yeh CB, Chang HA. The effects of add‐on Fronto‐temporal transcranial direct current stimulation (tDCS) on auditory verbal hallucinations, other psychopathological symptoms, and insight in schizophrenia: A randomized, double‐blind, sham‐controlled trial. Int. J. Neuropsychopharmacol. 2018; 21: 979–987. Brunelin J, Mondino M, Gassab L et al. Examining transcranial direct‐current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am. J. Psychiatry 2012; 169: 719–724. Jeon DW, Jung DU, Kim SJ et al. Adjunct transcranial direct current stimulation improves cognitive function in patients with schizophrenia: A double‐blind 12‐week study. Schizophr. Res. 2018; 197: 378–385. Palm U, Keeser D, Hasan A et al. Prefrontal transcranial direct current stimulation for treatment of schizophrenia with predominant negative symptoms: A double‐blind, sham‐controlled proof‐of‐concept study. Schizophr. Bull. 2016; 42: 1253–1261. Jackson MP, Rahman A, Lafon B et al. Animal models of transcranial direct current stimulation: Methods and mechanisms. Clin. Neurophysiol. 2016; 127: 3425–3454. Kronberg G, Rahman A, Sharma M, Bikson M, Parra LC. Direct current stimulation boosts hebbian plasticity in vitro. Brain Stimul. 2020; 13: 287–301. Liu H, Kaneko Y, Ouyang X et al. Schizophrenic patients and their unaffected siblings share increased resting‐state connectivity in the task‐negative network but not its anticorrelated task‐positive network. Schizophr. Bull. 2012; 38: 285–294. Hu ML, Zong XF, Mann JJ et al. A review of the functional and anatomical default mode network in schizophrenia. Neurosci. Bull. 2017; 33: 73–84. Hare SM, Ford JM, Mathalon DH et al. Salience–default mode functional network connectivity linked to positive and negative symptoms of schizophrenia. Schizophr. Bull. 2018; 45: 892–901. Skudlarski P, Jagannathan K, Anderson K et al. Brain connectivity is not only lower but different in schizophrenia: A combined anatomical and functional approach. Biol. Psychiatry 2010; 68: 61–69. Narita Z, Noda T, Setoyama S, Sueyoshi K, Inagawa T, Sumiyoshi T. The effect of transcranial direct current stimulation on psychotic symptoms of schizophrenia is associated with oxy‐hemoglobin concentrations in the brain as measured by near‐infrared spectroscopy: A pilot study. J. Psychiatr. Res. 2018; 103: 5–9. Gomes JS, Trevizol AP, Ducos DV et al. Effects of transcranial direct current stimulation on working memory and negative symptoms in schizophrenia: A phase II randomized sham‐controlled trial. Schizophr. Res. Cogn. 2018; 12: 20–28. Sreeraj VS, Dinakaran D, Parlikar R et al. High‐definition transcranial direct current simulation (HD‐tDCS) for persistent auditory hallucinations in schizophrenia. Asian J. Psychiatr. 2018; 37: 46–50. Hou W, Zhou F, Wang Q et al. Effect of transcranial direct current stimulation with concurrent cognitive performance targeting posterior parietal cortex vs prefrontal cortex on working memory in schizophrenia: A randomized clinical trial. Transl. Psychiatry 2024; 14: 279. |
Grant Information: |
TSGH-A-113015 Tri-Service General Hospital; 110-2628-B-016 -005 National Science and Technology Council; 111-2628-B-016-004 National Science and Technology Council; 112-2314-B-016-017-MY3 National Science and Technology Council; NSTC-109-2628-B-016-003 National Science and Technology Council; MND-MAB-D-112065 Medical Affairs Bureau, Ministry of National Defense |
Contributed Indexing: |
Keywords: clinical psychopathology; psychophysiology; schizophrenia |
PMID: |
39317963 |
|